This report provides a comprehensive analysis of the global cholesterol clinical testing services market, projecting significant growth through 2032. It evaluates key market dynamics, including the rising importance of lipid profiling in managing atherosclerosis risks. The study offers detailed segmentation by type, application, and geography, covering major regions such as the Americas, APAC, and Europe. Furthermore, it examines competitive landscapes and strategic activities of leading industry players to identify emerging opportunities and future market trajectories.

Market Overview

The global Cholesterol Clinical Testing Services market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Clinical Context

A cholesterol test, also referred to as a lipid panel or lipid profile, is a blood test designed to measure the levels of cholesterol and triglycerides in the blood. These tests are critical for determining the risk of fatty deposit (plaque) buildup in the arteries, a condition that can lead to systemic narrowing or blockage of the arteries, known as atherosclerosis.

Regional Market Analysis

• United States: The market for Cholesterol Clinical Testing Services is estimated to increase from 2025 through 2032, maintaining a consistent compound annual growth rate.
• China: The market for Cholesterol Clinical Testing Services is estimated to see an upward trend from 2025 through 2032, growing at a steady compound annual growth rate.
• Europe: The market for Cholesterol Clinical Testing Services is expected to grow from 2025 through 2032, expanding at a sustained compound annual growth rate.

Market Segmentation

By Type

• Hospital
• Clinical Laboratory
• Others

By Application

• Doctors/Providers and Hospitals
• Employers, Health Plans, and Managed Care Organizations (MCOs)
• Government Agencies
• Patients

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

Key Market Dynamics

In 2025, the global market was characterized by significant concentration, with the two largest companies occupying a substantial portion of the total market share.

Key Players

The following companies have been profiled based on primary expert input and analysis of their market coverage, product portfolios, and market penetration:

• Laboratory Corporation of America Holdings
• Quest Diagnostics
• Eurofins Scientific
• Spectra Laboratories
• Unilabs
• Synlab International
• Bio-Reference Laboratories
• Clinical Reference Laboratory
• ACM Medical Laboratory
• Adicon Clinical Laboratory
• PTS Diagnostics
• Healius
• DASA
• Life Labs
• Strand Life Sciences
• LSI Medience
• GC Labs
• Al Borg Diagnostics

Report Scope & Methodology

Research Objectives

LPI (LP Information)'s newest research report, the “Cholesterol Clinical Testing Services Industry Forecast,” provides a comprehensive analysis of the global landscape. The report:

• Reviews total global Cholesterol Clinical Testing Services sales for 2025.
• Provides a detailed analysis of projected sales for the period of 2026 through 2032.
• Breaks down sales by region, market sector, and sub-sector in US$ millions.
• Highlights key trends regarding product segmentation, company formation, revenue, market share, latest developments, and M&A activity.
• Analyzes the strategies of leading global companies, focusing on their portfolios, capabilities, market entry strategies, market positions, and geographic footprints.

Analytical Approach

This Insight Report evaluates key market trends, drivers, and affecting factors shaping the global outlook. It breaks down the forecast by Type, Application, Geography, and Market Size to identify emerging pockets of opportunity. The study utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a nuanced view of the current state and future trajectory of the global Cholesterol Clinical Testing Services market.

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Cholesterol Clinical Testing Services Market Size (2021-2032)

    • 2.1.2 Cholesterol Clinical Testing Services Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Cholesterol Clinical Testing Services by Country/Region (2021, 2025 & 2032)

  • 2.2 Cholesterol Clinical Testing Services Segment by Type

    • 2.2.1 Hospital

    • 2.2.2 Clinical Laboratory

    • 2.2.3 Others

    • 2.2.4 Cholesterol Clinical Testing Services Market Size by Type

      • 2.2.4.1 Cholesterol Clinical Testing Services Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.4.2 Global Cholesterol Clinical Testing Services Market Size Market Share by Type (2021-2026)

  • 2.3 Cholesterol Clinical Testing Services Segment by Application

    • 2.3.1 Doctors/Providers and Hospitals

    • 2.3.2 Employers, Health Plans, and Managed Care Organizations (MCOs)

    • 2.3.3 Government Agencies

    • 2.3.4 Patients

    • 2.3.5 Cholesterol Clinical Testing Services Market Size by Application

      • 2.3.5.1 Cholesterol Clinical Testing Services Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.5.2 Global Cholesterol Clinical Testing Services Market Size Market Share by Application (2021-2026)

• 3 Cholesterol Clinical Testing Services Market Size by Player

  • 3.1 Cholesterol Clinical Testing Services Market Size Market Share by Player

    • 3.1.1 Global Cholesterol Clinical Testing Services Revenue by Player (2021-2026)

    • 3.1.2 Global Cholesterol Clinical Testing Services Revenue Market Share by Player (2021-2026)

  • 3.2 Global Cholesterol Clinical Testing Services Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Cholesterol Clinical Testing Services by Region

  • 4.1 Cholesterol Clinical Testing Services Market Size by Region (2021-2026)

  • 4.2 Global Cholesterol Clinical Testing Services Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Cholesterol Clinical Testing Services Market Size Growth (2021-2026)

  • 4.4 APAC Cholesterol Clinical Testing Services Market Size Growth (2021-2026)

  • 4.5 Europe Cholesterol Clinical Testing Services Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Cholesterol Clinical Testing Services Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Cholesterol Clinical Testing Services Market Size by Country (2021-2026)

  • 5.2 Americas Cholesterol Clinical Testing Services Market Size by Type (2021-2026)

  • 5.3 Americas Cholesterol Clinical Testing Services Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Cholesterol Clinical Testing Services Market Size by Region (2021-2026)

  • 6.2 APAC Cholesterol Clinical Testing Services Market Size by Type (2021-2026)

  • 6.3 APAC Cholesterol Clinical Testing Services Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Cholesterol Clinical Testing Services Market Size by Country (2021-2026)

  • 7.2 Europe Cholesterol Clinical Testing Services Market Size by Type (2021-2026)

  • 7.3 Europe Cholesterol Clinical Testing Services Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Cholesterol Clinical Testing Services by Region (2021-2026)

  • 8.2 Middle East & Africa Cholesterol Clinical Testing Services Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Cholesterol Clinical Testing Services Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Cholesterol Clinical Testing Services Market Forecast

  • 10.1 Global Cholesterol Clinical Testing Services Forecast by Region (2027-2032)

    • 10.1.1 Global Cholesterol Clinical Testing Services Forecast by Region (2027-2032)

    • 10.1.2 Americas Cholesterol Clinical Testing Services Forecast

    • 10.1.3 APAC Cholesterol Clinical Testing Services Forecast

    • 10.1.4 Europe Cholesterol Clinical Testing Services Forecast

    • 10.1.5 Middle East & Africa Cholesterol Clinical Testing Services Forecast

  • 10.2 Americas Cholesterol Clinical Testing Services Forecast by Country (2027-2032)

    • 10.2.1 United States Market Cholesterol Clinical Testing Services Forecast

    • 10.2.2 Canada Market Cholesterol Clinical Testing Services Forecast

    • 10.2.3 Mexico Market Cholesterol Clinical Testing Services Forecast

    • 10.2.4 Brazil Market Cholesterol Clinical Testing Services Forecast

  • 10.3 APAC Cholesterol Clinical Testing Services Forecast by Region (2027-2032)

    • 10.3.1 China Cholesterol Clinical Testing Services Market Forecast

    • 10.3.2 Japan Market Cholesterol Clinical Testing Services Forecast

    • 10.3.3 Korea Market Cholesterol Clinical Testing Services Forecast

    • 10.3.4 Southeast Asia Market Cholesterol Clinical Testing Services Forecast

    • 10.3.5 India Market Cholesterol Clinical Testing Services Forecast

    • 10.3.6 Australia Market Cholesterol Clinical Testing Services Forecast

  • 10.4 Europe Cholesterol Clinical Testing Services Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Cholesterol Clinical Testing Services Forecast

    • 10.4.2 France Market Cholesterol Clinical Testing Services Forecast

    • 10.4.3 UK Market Cholesterol Clinical Testing Services Forecast

    • 10.4.4 Italy Market Cholesterol Clinical Testing Services Forecast

    • 10.4.5 Russia Market Cholesterol Clinical Testing Services Forecast

  • 10.5 Middle East & Africa Cholesterol Clinical Testing Services Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Cholesterol Clinical Testing Services Forecast

    • 10.5.2 South Africa Market Cholesterol Clinical Testing Services Forecast

    • 10.5.3 Israel Market Cholesterol Clinical Testing Services Forecast

    • 10.5.4 Turkey Market Cholesterol Clinical Testing Services Forecast

  • 10.6 Global Cholesterol Clinical Testing Services Forecast by Type (2027-2032)

  • 10.7 Global Cholesterol Clinical Testing Services Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Cholesterol Clinical Testing Services Forecast

• 11 Key Players Analysis

  • 11.1 Laboratory Corporation of America Holdings

    • 11.1.1 Laboratory Corporation of America Holdings Company Information

    • 11.1.2 Laboratory Corporation of America Holdings Cholesterol Clinical Testing Services Product Offered

    • 11.1.3 Laboratory Corporation of America Holdings Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Laboratory Corporation of America Holdings Main Business Overview

    • 11.1.5 Laboratory Corporation of America Holdings Latest Developments

  • 11.2 Quest Diagnostics

    • 11.2.1 Quest Diagnostics Company Information

    • 11.2.2 Quest Diagnostics Cholesterol Clinical Testing Services Product Offered

    • 11.2.3 Quest Diagnostics Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Quest Diagnostics Main Business Overview

    • 11.2.5 Quest Diagnostics Latest Developments

  • 11.3 Eurofins Scientific

    • 11.3.1 Eurofins Scientific Company Information

    • 11.3.2 Eurofins Scientific Cholesterol Clinical Testing Services Product Offered

    • 11.3.3 Eurofins Scientific Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Eurofins Scientific Main Business Overview

    • 11.3.5 Eurofins Scientific Latest Developments

  • 11.4 Spectra Laboratories

    • 11.4.1 Spectra Laboratories Company Information

    • 11.4.2 Spectra Laboratories Cholesterol Clinical Testing Services Product Offered

    • 11.4.3 Spectra Laboratories Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Spectra Laboratories Main Business Overview

    • 11.4.5 Spectra Laboratories Latest Developments

  • 11.5 Unilabs

    • 11.5.1 Unilabs Company Information

    • 11.5.2 Unilabs Cholesterol Clinical Testing Services Product Offered

    • 11.5.3 Unilabs Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Unilabs Main Business Overview

    • 11.5.5 Unilabs Latest Developments

  • 11.6 Synlab International

    • 11.6.1 Synlab International Company Information

    • 11.6.2 Synlab International Cholesterol Clinical Testing Services Product Offered

    • 11.6.3 Synlab International Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Synlab International Main Business Overview

    • 11.6.5 Synlab International Latest Developments

  • 11.7 Bio-Reference Laboratories

    • 11.7.1 Bio-Reference Laboratories Company Information

    • 11.7.2 Bio-Reference Laboratories Cholesterol Clinical Testing Services Product Offered

    • 11.7.3 Bio-Reference Laboratories Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Bio-Reference Laboratories Main Business Overview

    • 11.7.5 Bio-Reference Laboratories Latest Developments

  • 11.8 Clinical Reference Laboratory

    • 11.8.1 Clinical Reference Laboratory Company Information

    • 11.8.2 Clinical Reference Laboratory Cholesterol Clinical Testing Services Product Offered

    • 11.8.3 Clinical Reference Laboratory Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Clinical Reference Laboratory Main Business Overview

    • 11.8.5 Clinical Reference Laboratory Latest Developments

  • 11.9 ACM Medical Laboratory

    • 11.9.1 ACM Medical Laboratory Company Information

    • 11.9.2 ACM Medical Laboratory Cholesterol Clinical Testing Services Product Offered

    • 11.9.3 ACM Medical Laboratory Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 ACM Medical Laboratory Main Business Overview

    • 11.9.5 ACM Medical Laboratory Latest Developments

  • 11.10 Adicon Clinical Laboratory

    • 11.10.1 Adicon Clinical Laboratory Company Information

    • 11.10.2 Adicon Clinical Laboratory Cholesterol Clinical Testing Services Product Offered

    • 11.10.3 Adicon Clinical Laboratory Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Adicon Clinical Laboratory Main Business Overview

    • 11.10.5 Adicon Clinical Laboratory Latest Developments

  • 11.11 PTS Diagnostics

    • 11.11.1 PTS Diagnostics Company Information

    • 11.11.2 PTS Diagnostics Cholesterol Clinical Testing Services Product Offered

    • 11.11.3 PTS Diagnostics Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 PTS Diagnostics Main Business Overview

    • 11.11.5 PTS Diagnostics Latest Developments

  • 11.12 Healius

    • 11.12.1 Healius Company Information

    • 11.12.2 Healius Cholesterol Clinical Testing Services Product Offered

    • 11.12.3 Healius Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Healius Main Business Overview

    • 11.12.5 Healius Latest Developments

  • 11.13 DASA

    • 11.13.1 DASA Company Information

    • 11.13.2 DASA Cholesterol Clinical Testing Services Product Offered

    • 11.13.3 DASA Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 DASA Main Business Overview

    • 11.13.5 DASA Latest Developments

  • 11.14 Life Labs

    • 11.14.1 Life Labs Company Information

    • 11.14.2 Life Labs Cholesterol Clinical Testing Services Product Offered

    • 11.14.3 Life Labs Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 Life Labs Main Business Overview

    • 11.14.5 Life Labs Latest Developments

  • 11.15 Strand Life Sciences

    • 11.15.1 Strand Life Sciences Company Information

    • 11.15.2 Strand Life Sciences Cholesterol Clinical Testing Services Product Offered

    • 11.15.3 Strand Life Sciences Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 Strand Life Sciences Main Business Overview

    • 11.15.5 Strand Life Sciences Latest Developments

  • 11.16 LSI Medience

    • 11.16.1 LSI Medience Company Information

    • 11.16.2 LSI Medience Cholesterol Clinical Testing Services Product Offered

    • 11.16.3 LSI Medience Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.16.4 LSI Medience Main Business Overview

    • 11.16.5 LSI Medience Latest Developments

  • 11.17 GC Labs

    • 11.17.1 GC Labs Company Information

    • 11.17.2 GC Labs Cholesterol Clinical Testing Services Product Offered

    • 11.17.3 GC Labs Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.17.4 GC Labs Main Business Overview

    • 11.17.5 GC Labs Latest Developments

  • 11.18 Al Borg Diagnostics

    • 11.18.1 Al Borg Diagnostics Company Information

    • 11.18.2 Al Borg Diagnostics Cholesterol Clinical Testing Services Product Offered

    • 11.18.3 Al Borg Diagnostics Cholesterol Clinical Testing Services Revenue, Gross Margin and Market Share (2021-2026)

    • 11.18.4 Al Borg Diagnostics Main Business Overview

    • 11.18.5 Al Borg Diagnostics Latest Developments

• 12 Research Findings and Conclusion